Genomic and transcriptomic somatic alterations of hepatocellular carcinoma in non-cirrhotic livers
Authors: Skidmore Zachary L , Kunisaki Jason , Lin Yiing , Cotto Kelsy C , Barnell Erica K , Hundal Jasreet , Krysiak Kilannin , Magrini Vincent , Trani Lee , Walker Jason R , Fulton Robert , Brunt Elizabeth M , Miller Christopher A , Wilson Richard K , Mardis Elaine R , Griffith Malachi , Chapman William , Griffith Obi L 
Published: December 2021

AbstractBackgroundLiver cancer is the second leading cause of cancer-related deaths worldwide. Hepatocellular carcinoma (HCC) risk factors include chronic hepatitis, cirrhosis, and alcohol abuse, whereby tumorigenesis is induced through inflammation and subsequent fibrotic response. However, a subset of HCC arises in non-cirrhotic livers. We characterized the genomic and transcriptomic landscape of non-cirrhotic HCC to identify features underlying the disease’s development and progression.MethodsWhole genome and transcriptome sequencing was performed on 30 surgically resectable tumors comprised of primarily of non-cirrhotic HCC and adjacent normal tissue. Using somatic variants, capture reagents were created and employed on an additional 87 cases of mixed cirrhotic/non-cirrhotic HCC. Cases were analyzed to identify viral integrations, single nucleotide variants (SNVs), insertions and deletions (INDELS), copy number variants, loss of heterozygosity, gene fusions, structural variants, and differential gene expression.ResultsWe detected 3,750 SNVs/INDELS and extensive CNVs and expression changes. RecurrentTERTpromoter mutations occurred in >52% of non-cirrhotic discovery samples. Frequently mutated genes includedTP53,CTNNB1, andAPOB. Cytochrome P450 mediated metabolism was significantly downregulated. Structural variants were observed atMACROD2, WDPCPandNCKAP5in >20% of samples. Furthermore,NR1H4fusions involving gene partnersEWSR1, GNPTAB, andFNIP1were detected and validated in 2 non-cirrhotic samples.ConclusionGenomic analysis can elucidate mechanisms that may contribute to non-cirrhotic HCC tumorigenesis. The comparable mutational landscape between cirrhotic and non-cirrhotic HCC supports previous work suggesting a convergence at the genomic level during disease progression. It is therefore possible genomic-based treatments can be applied to both HCC subtypes with progressed disease.HighlightsNon-cirrhotic HCC genomically resembles cirrhotic HCCComprehensive genome- and transcriptome-wide profiling allows detection of novel structural variants, fusions, and undiagnosed viral infectionsNR1H4fusions may represent a novel mechanism for tumorigenesis in HCCNon-cirrhotic HCC is characterized by genotoxic mutational signatures and dysregulated liver metabolismClinical history and comprehensive omic profiling incompletely explain underlying etiologies for non-cirrhotic HCC highlighting the need for further researchShort DescriptionThis study characterizes the genomic landscape of hepatocellular carcinomas (HCCs) in non-cirrhotic livers. Using 117 HCCs tumor/normal pairs, we identified 3,750 SNVs/INDELS with high variant frequency in TERT,TP53,CTNNB1, andAPOB.CYP450was significantly downregulated and many structural variants were observed. This characterization could assist in elucidating non-cirrhotic HCC tumorigenesis.